Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy – retrospective analysis

Table 1 Main demographic and clinical data of the treated and control group

	Treated group	Control group	P value
Male: female	14:10	16:8	0.55
Age (years)	54.4 ± 12.3	55.4 ± 9.6	0.78
Follow-up (months)	22.7 ± 23.4	36.2 ± 24.2	0.04
Number vascular risk factors*	1.4 ± 1.1	1.6 ± 1.1	0.60
Crowded disc	10 (42%)	13 (54%)	0.31
Mean VA (LogMAR)	0.54 ± 0.67	0.54 ± 0.49	0.80
Visual field parameters
Mean quadrant involvement	2.4 ± 0.8	2.0 ± 0.6	0.007
Mean MD	9.7 ± 10.4	9.3 ± 10.5	0.9

VA = Visual acuity, MD = Mean deviation.
*Includes: Hypertention, diabetes mellitus, ischemic heart disease, dyslipidemia and smoking.

ISSN: 1471-2415